Unknown

Dataset Information

0

Immune Checkpoint Blockade for Breast Cancer.


ABSTRACT: An effective antitumor immune response requires interaction between cells of the adaptive and innate immune system. Three key elements are required: generation of activated tumor-directed T cells, infiltration of activated T cells into the tumor microenvironment, and killing of tumor cells by activated T cells. Tumor immune evasion can occur as a result of the disruption of each of these three key T cell activities, resulting in three distinct cancer-immune phenotypes. The immune inflamed phenotype, characterized by the presence of a robust tumor immune infiltrate, suggests impaired activated T cell killing of tumor cells related to the presence of inhibitory factors. Programmed death receptor-1 (PD-1) is an inhibitory transmembrane protein expressed on T cells, B cells, and NK cells. The interaction between PD-1 and its ligands (PD-L1/L2) functions as an immune checkpoint against unrestrained cytotoxic T effector cell activity-it promotes peripheral T effector cell exhaustion and conversion of T effector cells to immunosuppressive T regulatory (Treg) cells. Immune checkpoint inhibitors, which block the PD-1/PD-L1 axis and reactivate cytotoxic T effector cell function, are actively being investigated for the treatment of breast cancer.

SUBMITTER: Swoboda A 

PROVIDER: S-EPMC6061922 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immune Checkpoint Blockade for Breast Cancer.

Swoboda April A   Nanda Rita R  

Cancer treatment and research 20180101


An effective antitumor immune response requires interaction between cells of the adaptive and innate immune system. Three key elements are required: generation of activated tumor-directed T cells, infiltration of activated T cells into the tumor microenvironment, and killing of tumor cells by activated T cells. Tumor immune evasion can occur as a result of the disruption of each of these three key T cell activities, resulting in three distinct cancer-immune phenotypes. The immune inflamed phenot  ...[more]

Similar Datasets

| S-EPMC8718579 | biostudies-literature
| S-EPMC3587160 | biostudies-literature
| S-EPMC5290437 | biostudies-literature
| S-EPMC7487859 | biostudies-literature
| S-EPMC8574993 | biostudies-literature
2024-06-23 | PXD051061 | Pride
| S-EPMC5822709 | biostudies-literature
| S-EPMC7910743 | biostudies-literature
| S-EPMC5629093 | biostudies-literature
| S-EPMC4910761 | biostudies-literature